Bayraktar, A. Et Al. 2020. Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?. TRANSPLANTATION PROCEEDINGS , vol.52, no.1 , 97-101.

Bayraktar, A., Akgul, S. U., Bakkaloglu, H., Temurhan, S., Cinar, Ç., Ciftci, H. S., ... Gok, A. F. K.(2020). Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?. TRANSPLANTATION PROCEEDINGS , vol.52, no.1, 97-101.

Bayraktar, Adem Et Al. "Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?," TRANSPLANTATION PROCEEDINGS , vol.52, no.1, 97-101, 2020

Bayraktar, Adem Et Al. "Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?." TRANSPLANTATION PROCEEDINGS , vol.52, no.1, pp.97-101, 2020

Bayraktar, A. Et Al. (2020) . "Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?." TRANSPLANTATION PROCEEDINGS , vol.52, no.1, pp.97-101.

@article{article, author={Adem BAYRAKTAR Et Al. }, title={Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?}, journal={TRANSPLANTATION PROCEEDINGS}, year=2020, pages={97-101} }